According to Sudarshan Sukhani of s2analytics.com, positional traders should buy Ranbaxy Laboratories and hold it for a few weeks. He feels after a consolidation of many days Ranbaxy is probably now willing to go higher again.
first published: May 7, 2013 11:06 am
A collection of the most-viewed Moneycontrol videos.
Live: Nifty recovers 100 pts from day's lows in a choppy session; smallcaps shine | Closing Bell
Live: Can Nifty reclaim 26,000 after RS 7.5 lakh crore selloff? | IndiGo in focus | Opening Bell
Live: Sensex, Nifty fall 1% amidst broad-based selloff | Closing Bell
Live: Can Nifty reclaim record levels as investors await FOMC decision this week? | Opening Bell
